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Abstract
Background: Variceal upper gastrointestinal bleeding (UGIB) is common in sub-Saharan Africa (SSA). However, poor access 
to endoscopy services precludes the diagnosis of  varices.
Objectives: We determined the diagnostic accuracy of  routine clinical findings for detection of  esophageal varices among pa-
tients with UGIB in rural SSA where schistosomiasis is endemic.
Methods: We studied patients with a history of  UGIB. The index tests included routine clinical findings and the reference test 
was diagnostic endoscopy. Multivariable regression with post-estimation provided measures of  association and diagnostic accu-
racy.
Results: We studied 107 participants with UGIB and 21% had active bleeding. One hundred and three (96%) had liver disease 
and 86(80%) varices. Factors associated with varices (p-value <0.05) were ≥ 4 lifetime episodes of  UGIB, prior blood trans-
fusion, splenomegaly, liver fibrosis, thrombocytopenia, platelet count spleen diameter ratio <909, and a dilated portal vein. 
Two models showed an overall diagnostic accuracy of  > 90% in detection of  varices with a number needed to misdiagnose of  
13(number of  patients who needed to be tested in order for one to be misdiagnosed by the test).
Conclusion:  Where access to endoscopy is limited, routine clinical findings could improve the diagnosis of  patients with UGIB 
in Africa.
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ran Africa where schistosomiasis is endemic.
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Introduction
Endoscopy is recommended for anyone with a history 
of  upper gastrointestinal bleeding (vomiting blood or 
passing black stool or rarely, passing frank blood in one's 
stool). It is the most accurate and best available diagnostic 
test for upper gastrointestinal bleeding1,2. On the other 
hand, limited access to endoscopy is associated with poor 
disease outcomes3,4. In sub-Saharan Africa (SSA), upper 
gastrointestinal bleeding (UGIB) is a frequent cause of  
hospitalization and death5–8. It is mainly due to bleed-
ing esophageal varices and is a complication of  chronic 
schistosomiasis and/or liver cirrhosis. Diagnosis of  var-
ices and UGIB in SSA is challenging because of  limited 
access to endoscopy9,10. This has had undesirable effects 
like increased frequency of  death7,11,12. Just a few stud-
ies have identified potential surrogates to endoscopy for 
diagnosis of  UGIB or varices. These include thrombo-
cytopenia, splenomegaly, an abnormal platelet count/
spleen diameter ratio, and ultrasound periportal fibrosis 
patterns13–16. However, none of  these parameters have 
been studied at any primary health care settings in rural 
SSA were endoscopy services are absent. We studied the 
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diagnostic accuracy of  routine clinical findings for de-
tection of  esophageal varices among patients reporting 
one or more lifetime episodes of  upper gastrointestinal 
bleeding. Our study was conducted at a primary health 
facility in rural sub-Saharan Africa where schistosomiasis 
is endemic and access to endoscopy is limited.
Materials and methods
Overview
Our study was part of  one study that profiled upper gas-
trointestinal bleeding17.  It was a diagnostic accuracy study 
at Pakwach Health Centre IV in Northwestern Uganda. 
We enrolled participant’s ≥12 years of  age, with a history 
of  UGIB and/or admitted for acute severe UGIB. For 
each participant, we obtained consent and administered 
a questionnaire collecting information on current or past 
history of  UGIB. We then performed a physical exam-
ination, laboratory tests, and liver sonography. The above 
were performed independently of  the endoscopy team.
Diagnostic endoscopy
All participants were eligible for a diagnostic endoscopy 
and underwent diagnostic upper digestive endoscopy. No 
participant was excluded for any reason. Endoscopy was 
performed in the unit's operating theatre by a trained gas-
troenterologist and his team using a Pentax EPKi digital 
video processor and Pentax 9.8mm video gastroscope18. 
The esophagus, stomach, and duodenum were examined 
for evidence of  UGIB or cause of  UGIB with emphasis 
on varices, esophageal or gastric/duodenal erosions or 
ulcers18. Endoscopic findings were reported as recom-
mended by the Japanese research for Portal Hyperten-
sion, and/or the modified Forrest classification for upper 
gastrointestinal bleeding19,20. The report was written and 
pictures saved. Results were communicated to each par-
ticipant; appropriate treatment given (propanolol for vari-
ces or triple therapy for peptic ulcer disease or hematinics 
for anemia), and linkage to care ensured.
Ethical approval was obtained from the School of  Med-
icine Research and Ethics Committee of  Makerere Uni-
versity College of  Health Sciences, and the Uganda Na-
tional Council for Science and Technology. Our study was 
carried out in accordance with the principles expressed in 
the Declaration of  Helsinki. Written informed consent 
was obtained from all participants.
Data management and analysis
The reference standard test was endoscopy. The depen-
dent variable was esophageal varices and independent 
variables were routine clinical findings. Data was record-
ed in forms and transcribed into Microsoft Access da-
tabase software 2007 (Microsoft Corporation) daily and 
exported to Stata version 13 (StataCorp, Lakeway, College 
Station, Texas, USA) for analysis. Descriptive statistics in-
cluded frequencies and proportions. Inferential statistics 
involved logistic regression with esophageal varices as the 
dependent variable. A significance level (p-value < 0.05) 
was chosen. Odds ratios and confidence intervals were 
used for inference. Purposeful selection of  covariates was 
performed and models generated. The best-fit model was 
selected on clinical plausibility, Akaike information cri-
terion, and Bayesian information criterion. The outputs 
of  the 2 best-fit models were represented graphically as 
nomograms. Post-estimation in Stata generated measures 
of  diagnostic accuracy by a confusion matrix for the best 
two models and other clinical parameters associated with 
esophageal varices. Measures of  diagnostic accuracy in-
cluded specificity, sensitivity, positive predictive value, 
negative predictive value, correct classification rate (over-
all accuracy), and number needed to misdiagnose-number 
of  patients who needed to be tested in order for one to 
be misdiagnosed by the test21–24. These results are detailed 
in the subsequent text and tables.
Results
From July to August 2014, one hundred and seven par-
ticipants underwent endoscopy to determine the possible 
cause of  their UGIB. Eighty-four (78%) were outpatients 
and 23 (22%) in-patients with severe acute UGIB (Figure 
1). 
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The youngest and oldest participants were 25 years and 
75 years of  age respectively. The median age was 45 years 
and IQR 13 years. Sixty-four (60%) were females, all par-
ticipants reported ≥2 contacts with the waters of  the 
Nile every week, 94(88%) reported prior treatment with 
praziquantel, 103 (96%) reported a past admission for 
UGIB, and none of  the study participants had ever had 
an endoscopy. Among the 107 participants, 57% (95% CI 
47%-66%) experienced two or more episodes of  UGIB 
during their lifetime. At ultrasonography 92% had liver 
disease with 40% having cirrhosis and 60% had peripor-
tal fibrosis. We found esophageal varices in 80% (95% 
CI, 72%-87%), gastric varices in 17% (95% CI, 11-25%), 
portal hypertensive gastropathy 78% (95% CI, 69%-
84%), and actively bleeding or oozing gastric or duodenal 
mucosa in 10% (Table 1). 
PAKWACH HEALTH CENTRE IV
Informed consent, ≥12 years, Upper gastrointestinal bleeding ( UGIB)
All patients presenting to outpatients’ 
with≥ 1 lifetime episodes of  UGIB 
All patients admitted with a diagnosis of  acute 
severe UGIB of  6 weeks 
Procedures: History, physical examination, blood and urine for laboratory examination, trans-abdominal ultrasound
84 out of  324 outpatients were 
enrolled after systematic sampling 
23 participants admitted with acute severe 
UGITB were enrolled
Procedures: informed consent, endoscopy, data analysis
Out patients’ Inpatients
Varices
67 (80%)
No varices
17(20%)
Varices
19(83%)
No Varices
4 (17%)
Figure 1. Study flowchart describing enrollment and the proportion of participants from   outpatients and inpatients with esophageal varices. 
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Table 1. Endoscopy findings, their proportions, and/or 95% confidence intervals for proportions 
 
Endoscopy findings N (%) 95% CI (%) 
Esophageal varices present 86(80%) (72%-87%) 
Grades of varices 
F0: lesions assuming no varicose appearance 
F1: straight small-calibered varices 
F2: moderately enlarged, beady varices 
F3: markedly enlarged, nodular, or tumor-shaped varices 
  
21 (19.6%) 
12 (11.1%) 
32 (29.9%) 
42 (39.4%) 
  
Red color sign (RC) with esophageal varices 
Red wale marking, cherry Red Spot, hematocytic spot 
RC0: absent 
RC1: small in number and localized 
RC2: intermediate between 1 and 3 
RC3: large in number and circumferential 
  
  
11 (12.8%) 
10 (11.6%) 
27 (31.3%) 
38 (44.2%) 
  
Esophageal varices with 
Gushing 
Spurting 
Red plug 
White plug 
  
0 
2 (2%) 
13 (12%) 
8 (8%) 
  
Gastric varices present 18(17%) (11%-25%) 
Portal hypertensive gastropathy (mosaic pattern) 83 (78%) (69%-84%) 
Abnormal mucosa stomach or duodenal mucosa (erosions or 
ulcerations) and presence of stigmata of bleeding 
 Forrest classification 
    
I a (spurting hemorrhage) 
Ib (oozing hemorrhage) 
0 
11 (10%) 
  
  
IIa&b (non bleeding visible vessel or adherent clot) 
II c (flat pigmented hematin) 
0 
1 (1%) 
  
III (lesions without any signs of recent hemorrhage or fibrin) 17 (16%) 
  
  
 
A number of  routine clinical findings were more fre-
quent and more likely to occur among those with varices 
than those without varices (95% CI for odds ratio >1) at 
univariable analysis. These included having ≥ 4 lifetime 
episodes of  UGIB, prior history of  blood transfusion, 
palpable spleen, WHO ultrasound periportal fibrosis pat-
terns DEF or X, platelet count ≤140 x109/L, platelet 
count /spleen diameter ratio ≤909, portal vein diameter 
≥13 mm (Table 2). 
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At multivariable logistic regression we identified two of  
the best-fit models 1 and 2. These are summarized vi-
sually as two nomograms, Figure 2 and Figure 3. These 
represent an approximate graphical computation of  a 
mathematical function of  each model. The sums of  the 
scores of  all factors in the graphs indicate the predicted 
probability of  having varices. This is obtained by linking 
the total scores with the corresponding probability. The 
diagnostic accuracy of  these clinical factors and statistical 
models are summarized in Table 3. All factors were found 
to have very good sensitivity (>90%) while model 1 and 
2 had the best specificity. Model 1 and 2 had the best 
number needed to misdiagnose esophageal varices of  13.
Factor variables Varices
N (%)
No varices
N (%)
Crude odds ratios (95%CI)
Age ≤39 years 25 (29) 4 (19) 1.7 (0.5-6)
Female gender 53 (62) 11 (52) 1.5 (0.6-3.8)
Born in Pakwach 67 (78) 15 (71) 1.4 (0.5-4.1)
Resident in Pakwach> 10 years 77 (90) 17 (81) 2.0 (0.6-7.3)
>2 contacts a week with the waters of the Nile 86 (100) 21 (100) -
Farmer (occupation) 63 (73) 16 (76) 0.9 (0.3-2.6)
Prior Praziquantel use 75 (87) 18 (85) 1.1 (0.3-4.5) 
Previously admitted for upper gastrointestinal bleeding 84 (98) 19 (90) 4.4 (0.6-33.4)
Currently admitted for severe acute variceal bleeding 19 (22) 4 (19) 1.2 (0.4-4) 
Number lifetime of episodes of upper gastrointestinal bleeding 
1 
2-3 
4 and more 
33 (39)
27 (31)
26 (30)
13 (62)
7 (33)
1 (5) 
2.4 (1.2-4.9)*
Previous blood transfusion 64 (72) 9 (43) 3.9 (1.4-10.5)*
Alcohol use 4 (5) 0 -
Jaundice 10 (11) 1 (5) 2.6 (0.3-21.8)
Ascites 17 (20) 1 (5) 4.9 (0.6-39.3)
Liver flap 8 (9) 2 (10) 0.9 (0.2-4.9)
Edema  11 (13) 1 (5)
#Splenomegaly at palpation 78 (96) 14 (67) 13 (3-56) *
WHO ultrasound patterns
A+C 
D+E+F
X
1 (1)
51 (59)
34 (40)
8 (38)
8 (38)
5 (24)
4.8 (1.9-12.3)* 
Platelet count spleen diameter ratio ≤909 79 (92) 6 (29) 28 (8-96)*
Portal vein diameter ≥13 mm 69 (80) 10 (48) 4.5 (1.6-12.2)*
Hepatitis B surface antigen positive 5 (6) 2 (9) 0.54 (0.1-3.25)
Hepatitis C-antibody positive 21 (24) 7 (33) 0.65 (0.23-1.81)
Urine circulating cathodic antigen positive 5 (6) 4 (19) 0.26 (0.06-1.07)
Platelet count ≤ 140 x109/L 82 (95) 12 (43) 27 (7.3-103)*
Hemoglobin level ≤80g/L 26 (30) 6 (29) 1.1 (0.4-3.1)
*P-value <0.05; 95% confidence intervals do not cross 1, #5 missing evaluations due to tense ascites.
Table 2. Routine clinical findings associated with the presence of  esophageal varices at endoscopy: proportions, crude odds ratios, 
and their 95% confidence intervals.
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Figure 2. A nomogram of model 1 consisting of platelet count spleen diameter ratio ≤909,  
WHO peri-portal fibrosis patterns EF or X, number lifetime of episodes of UGIB≥4,  
heart rate ≥68beats/minute. This enables one to calculate output probabilities for predictive  
models with a visual approach. Estimate the probability of having varices through 3 steps.  
Step 1 -establish scores for all variable values, step 2-obtain the total score adding up all the  
scores obtained in the previous step, step 3-obtain the probability of the event (total Score ->  
Probability of event). 
 
 
  
 
Figure 3. A nomogram of model 2 consisting of includes age ≤39 years, heart rate ≥68 beats/minute, palpable spleen,  
≥4 Number lifetime of episodes of UGIB, platelet count< 140x109/L This enables one to calculate output  
probabilities for predictive models with a visual approach. Estimate the probability of having varices through 3 steps.  
Step 1 -establish scores for all variable values, step 2-obtain the total score adding up all the scores obtained in the  
previous 
step, step 3-obtain the probability of the event (total Score -> Probability of event). 
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Discussion
These results showed our two models of  different rou-
tine clinical findings demonstrated good diagnostic ac-
curacy in detecting esophageal varices. To our knowl-
edge, this is the first study from a primary health facility 
in rural SSA that has studied detection of  varices using 
clinical findings. We chose participants with UGIB be-
cause UGIB is a well-defined indication for endoscopy4,20. 
Most participants had recurrent UGIB (≥2 episodes of  
UGIB). Recurrent UGIB is with associated varices, fur-
ther re-bleeding, and greatest risk of  death25. Like most 
studies from SSA, we found esophageal varices were the 
most common endoscopic finding in UGIB6–8,26. This 
contrasts with other parts of  the world where peptic ul-
cer disease is the most frequent endoscopic finding27,28. 
As other researchers, we identified clinical findings that 
were associated with varices7,29–32. However, our models 
1 and 2 have not been described elsewhere. These two 
models showed the highest accuracy and best diagnostic 
test effectiveness than any other routine clinical finding. 
Model 1 is distinct in that requires ultrasonography unlike 
model 2 that involves only a medical history, a physical 
examination, and platelet count. A manual platelet count 
is possible in every rural health facility laboratory33. Ab-
dominal ultrasonography has the advantage of  simpli-
fying diagnosis of  periportal fibrosis, to a lesser extent 
liver cirrhosis, and other hepatobiliary diseases such as 
hepatocellular cancer, gallstones, portal vein thrombosis, 
and others34,35. Our nomograms have potential advantag-
es for rural health facilities. They permit straightforward 
Diagnostic tests N Sensitivity
(95%CI)
Specificity
(95%CI)
PPV
(95%CI)
NPV
(95%CI)
Accuracy
(95%CI)
NNM
(95%CI)
Model 1 (involves ultrasonography) 107 97%
(90-99%)
71%
(48-89%)
93%
(88-97%)
83%
(61-94%)
92%
(85-96%)
13
(7-25)
Model 2 (no ultrasonography) 102 96%
(90-99%)
76%
(53-92%)
94%
(89-97%)
84%
(63-94%)
92%
(85-97%)
13
(7-25)
Platelet count spleen diameter ratio <909 107 92%
(84-97%)
71%
(48-89%)
93%
(87-96%)
68%
(50-82%)
88%
(80-93%)
8
(5-14)
≥4 Number lifetime of episodes of
upper gastrointestinal bleeding (UGIB)
107 100%
(96-100%)
0
(0-16%)
83%
-
-
-
80%
(72-87%)
5
(4-8)
Fibrosis patterns EF or X* 107 99%
(94-100%)
38%
(18-62%)
87%
(82-90%)
89%
(51-98%)
87%
(79-93%)
8
(5-14)
Palpable spleen 102 96%
(90-99%)
33%
(15-57%)
85%
(80-88%)
70%
40-89%
83%
(79-90%)
6
(5-10)
Platelet count ≤140 x109/L 107 95%
(89-99%)
57%
(34-79%)
90%
(85-94%)
75%
(56-89%)
88%
(80-93%)
8
(5-14)
Heart rate ≥68beats/min 107 100%
(96-100%)
0
(0-16%)
80%
-
- 80%
(72-87%)
5
(4-8)
Age ≤39 years 107 100%
(96-100%)
0
(0-16%)
80%
-
-
-
80%
(72-87%)
5
(4-8)
Model 1 includes following factor variables platelet count spleen diameter ratio <909, WHO periportal fibrosis patterns EF or X, number lifetime of episodes of UGIB≥4, heart rate ≥68beats/minute. 
Model 2 includes age ≤39 years, heart rate ≥68 beats/minute, palpable spleen, ≥4 Number lifetime of episodes of UGIB, platelet count≤ 140 x 109 /L.  
PPV- positive predictive value, NPV-negative predictive value, NNM – number needed to misdiagnose.
Table 3. The diagnostic accuracy of routine clinical findings or their combinations for detection of esophageal varices
in rural Africa where schistosomiasis is endemic: diagnostic tests, study size, and measures of diagnostic accuracy.
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estimation of  each individual patient’s test probability, are 
simple to understand, can be mass-produced at low cost, 
and can be easilyalidated23. We acknowledge that these 
models cannot replace endoscopy as the diagnostic test 
of  choice for detection of  varices. However, nomograms 
have the potential to strengthen clinical decision making 
in settings were endoscopy is poorly accessible. Specifi-
cally, these nomograms could assist in prioritizing referral 
of  patients for endoscopy; justifying the use of  emergen-
cy medications like terlipressin in acute variceal bleeding 
and/or chronic use of  propranolol to prevent recurrent 
variceal bleeding while awaiting endoscopy31,36,37. Using 
emergency drugs as terlipressin or ocreotide controls 
acute variceal hemorrhage is effective in up to 90% of  
individuals with bleeding varices38. While chronic treat-
ment with propranolol decreases the risk of  re-bleeding 
from 80% to 20% over one year among patients with 
Schistosomiasis31.
Study limitations
Our study has limitations. It was a single center study in 
a distinct rural community. This limits its generalizability. 
We also concede that having a larger study sample size 
would decrease the uncertainty of  some of  our findings.
Conclusion
Nomograms consisting of  routine clinical findings effec-
tively detect varices in adults with UGIB, schistosomiasis 
and/or cirrhosis. These nomograms are potential diag-
nostic triage tests for detection of  varices in areas where 
schistosomiasis is endemic and access to endoscopy is 
limited.
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